Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine

Carcinogenesis

Volumn 21, Issue 2, 2000, Pages 195-203

  Salim, Elsayed I ^a   Wanibuchi, Hideki ^a   Morimura, Keiichirou ^a   Kim, Shokei ^a   Yano, Yoshihisa ^a   Yamamoto, Shinji ^a   Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 PROPANEDIAMINE; ASCORBIC ACID; BROXURIDINE; CYCLIN D1; MESSENGER RNA; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; ORNITHINE DECARBOXYLASE; ORNITHINE DECARBOXYLASE INHIBITOR; TUMOR PROMOTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOGENESIS; BLADDER MUCOSA; BLADDER PAPILLOMA; CANCER INCIDENCE; CANCER INHIBITION; CELL LABELING; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

EID: 0033982653     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.2.195     Document Type: Article

References (65)

1. Fukushima, S., Wanibuchi, H. and Yamamoto, S. (1999) Urinary bladder cancer. In Kitchin, K.T. (ed.) Carcinogenicity. Testing, Predicting, and Interpreting Chemical Effects, Marcel Dekker Inc., USA, pp. 627-652.
2. El-Merzabani, M.M., El-Aaser, A.A. and Zakhary, N.I. (1979) A study on the aetiological factors of bilharzial bladder cancer in Egypt, 1. Nitrosamines and their precursors in urine. Eur. J. Cancer, 15, 287-291.
3. Pegg, A.E. (1988) Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res., 48, 759-774.
4. Heby, O. and Persson, L. (1990) Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem. Sci., 15, 153-158.
5. Smith, M.K., Goral, M.A., Wright, J.H., Matrisian, L.M., Morris, R.J., Klein-Szanto, A.J. and Gilmour, S.K. (1997) Ornithine decarboxylase overexpression leads to increased epithelial tumor invasiveness. Cancer Res., 57, 2104-2108.
6. 1-acetyltransferase, a new biochemical marker for epithelial proliferation in rat bladder. Jpn. J. Cancer Res., 83, 1037-1040.
7. Berdinskikh, N.K., Ignatenko, N.A., Zaletok, S.P., Ganina, K.P. and Chorniy, V.A. (1991) Ornithine decarboxylase activity and polyamine content in adenocarcinomas of human stomach and large intestine. Int. J. Cancer, 47, 496-498.
8. Manen, C.A., Hood, R.D. and Farina, J. (1983) Ornithine decarboxylase inhibitors and fetal growth retardation in mice. Teratology, 28, 237-242.
9. Seely, J.E. and Pegg, A.E. (1983) Effect of 1,3-diaminopropane on ornithine decarboxylase enzyme protein in thioacetamide-treated rat liver. Biochem. J., 216, 701-707.
10. Janne, J. Alhonen, L. and Leinonen, P. (1991) Polyamines: from molecular biology to clinical applications. Ann. Med., 23, 241-259.
11. Homma, Y., Kakizoe, T., Samma, S. and Oyasu, R. (1987) Inhibition of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by α-difluoromethylornithine. Cancer Res., 47, 6176-6179.
12. McCann, P.P. and Pegg, A.E. (1992) Ornithine decarboxylase as an enzyme target for therapy. Pharmacol. Ther., 54, 195-215.
13. Iishi, H., Tatsuta, M., Baba, M., Okuda, S. and Taniguchi, H. (1992) Attenuating effect of ornithine decarboxylase inhibitor (1,3-diaminopropane) on bombesin enhancement of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine. Int. J. Cancer, 50, 311-314.
14. Iishi, H., Tatsuta, M., Baba, M., Yano, H., Sakai, N., Uehara, H. and Nakaizumi, A. (1997) Ornithine decarboxylase inhibitor lessens the rat gastric carcinogenesis enhancement caused by tyrosine methyl ester. Int. J. Cancer, 73, 113-116.
15. Tatsuta, M., Iishi, H., Baba, M., Yano, H., Uehara, H. and Nakaizumi, A. (1995) Ornithine decarboxylase inhibitor attenuates NaCl enhancement of gastric carcinogenesis induced by N-methyl-N′ -nitro-N-nitrosoguanidine. Carcinogenesis, 16, 2107-2110.
16. Iishi, H., Tatsuta, M., Baba, M., Uehara, H. and Nakaizumi, A. (1994) Ornithine decarboxylase inhibitor attenuates bombesin enhancement of intestinal carcinogenesis and metastasis induced by azoxymethane. Int. J. Cancer, 58, 533-537.
17. Tatsuta, M., Iishi, H., Baba, M., Yamamoto, R., Uehara, H. and Nakaizumi, A. (1995) Attenuation of vasoactive intestinal peptide enhancement of colon carcinogenesis by ornithine decarboxylase inhibitor. Cancer Lett., 93, 219-225.
18. Fukushima, S., Imaida, K., Sakata, T., Okamura, T., Shibata, M. and Ito, N. (1983) Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. Cancer Res., 43, 4454-4457.
19. Shirai, T., Ikawa, E., Fukushima, S., Masui, T. and Ito, N. (1986) Uracil-induced urolithiasis and the development of reversible papillomatosis in the urinary bladder of F344 rats. Cancer Res., 46, 2062-2067.
20. Babaya, K., Izumi, K., Ozono, S., Miyata, Y., Morikawa, A., Chmiel, J.S. and Oyasu, R. (1983) Capability of urinary components to enhance ornithine decarboxylase activity and promote urothelial tumorigenicity. Cancer Res., 43, 1774-1782.
21. 1-acetyltransferase activity by treatment with lithium chloride in Ehrlich ascites tumor cells. Chem. Biol. Interact., 81, 233-242.
22. Otani, K., Yano, Y., Hasuma, T., Arakawa, T., Kobayashi, K., Matsui-Yuasa, I. and Otani, S. (1998) Polyamine metabolism of rat gastric mucosa after oral administration of hypertonic sodium chloride solution. Am. J. Physiol., 274, 299-305.
23. O'Brien, T.G., Megosh, L.C., Gilliard, G. and Soler, A.P. (1997) Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res., 57, 2630-2637.
24. Auvinen, M., Paasinen, A., Andersson, L.C. and Holtta, E. (1992) Ornithine decarboxylase activity is critical for cell transformation. Nature, 360, 355-358.
25. Homma, Y., Kakizoe, T., Samma, S. and Oyasu, R. (1989) Suppression of rat urinary bladder carcinogenesis by α-difluoromethylornithine. J. Urol., 141, 1454-1457.
26. Samaha, H.S., Kelloff, G.J., Steele, V.E., Rao, C.V. and Reddy, B.S. (1997) Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res., 57, 1301-1305.
27. Tang, B., Bottinger, E.P. Jakowlew, S.B., Bangall, K.M., Mariano, J., Anver, M.R., Letterio, J.J. and Wakefield, L.M. (1998) Transforming growth factor-betal is a new form of tumor suppressor with true haploid insufficiency. Nature Med., 4, 802-807.
28. Lin, P., Sankar, S., Shan, S., Dewhirts, M.W., Polverini, P.J., Quinn, T.Q. and Peters, K.G. (1998) Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Differ., 9, 49-58.
29. Matsushime, H., Roussel, M.F., Ashmun, R.A. and Sherr, C.J. (1991) Colony-stimulating factor I regulates novel cyclins during the G1 phase of the cell cycle. Cell, 65, 701-713.
30. Grana, X. and Reddy, E.P. (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes, and cyclin-dependent kinase inhibitors. Oncogene, 11, 211-219.
31. Sidransky, D., Von Eschenbach, A., Tsai, Y.C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S.R., Frost, P. and Vogelstein, B. (1991) Identification of p53 gene mutations in bladder cancer and urine samples. Science, 252, 706-709.
32. Lee, C. C., Yamamoto, S., Wanibuchi, H., Wada, S., Sugimura, K., Kishimoto, T. and Fukushima, S. (1997) Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation. Cancer Res., 57, 4765-4776.
33. Fukushima, S., Murasaki, G., Hirose, M., Nakanishi, K., Hasegawa, R. and Ito, N. (1982) Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats. Acta Pathol. Jpn, 32, 243-250.
34. Otani, S., Matsui, I., Kuramoto, A. and Morisawa, S. (1985) Induction of ornithine decarboxylase in guinea-pig lymphocytes: synergistic effects of diacylglycerol and calcium. Eur. J. Biochem., 147, 27-31.
35. Matsushime, H., Ewen, M.E., Storm, D.K., Kato, J.Y., Hanks, S.K., Roussel, M.F. and Sherr, C.J. (1992) Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins, Cell, 71, 323-334.
36. Conn, C., Bayne, M.L., Soderman, D.D., Kwok, P.W., Sullivan, K.A., Palisi, T.M., Hope, D.A. and Thomas, K.A. (1990) Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl Acad. Sci. USA, 87, 2628-2632.
37. Fort, P., Marty, L., Piechaczyk, M., el Sabrouty, S., Dani, C.H., Jeanteur, P.H. and Blanchard, J.M. (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res., 13, 1431-1442.
38. Moshier, J.A., Dosescu, J., Skunca, M. and Luk, G.D. (1993) Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res., 53, 2618-2622.
39. Cohen, S.M. and Ellwein, L.B. (1991) Genetic errors, cell proliferation and carcinogenesis. Cancer Res., 51, 6493-6505.
40. Said, T.K. and Medina, D. (1995) Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development. Carcinogenesis, 16, 823-830.
41. Albrecht, J.H., Poon, R.Y., Ahonen, C.L., Rieland, B.M., Deng, C. and Crary, G.S. (1998) Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Oncogene, 16, 2141-2150.
42. Liu, S.C., Sauter, E.R., Clapper, M.L., Feldman, R.S., Levin, L., Chen, S.Y., Yen, T.J., Ross, E., Engstorm, P.F. and Klein-Szanto, A.J. (1998) Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity. Cancer Epidemiol. Biomarkers Prev., 7, 597-603.
43. Weinstein, I.B. (1996) Relevance of cyclin D1 and other molecular markers to cancer chemoprevention. J. Cell. Biochem., 25 (suppl.), 23-28.
44. Boyle, J.O., Langenfeld, J., Lonardo, F., Sekula, D., Reczek, P., Rusch, V., Dawson, M.I. and Dmitrovsky, E. (1999) Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. J. Natl Cancer Inst., 91, 373-379.
45. Seewaldt, V.L, Dietze, E.C., Johnson, B.S., Collins, S.J. and Parker, M.B. (1999) Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression. Cell Growth Differ., 10, 49-59.
46. Campbell, S.C., Volpert, O.V., Ivanovich, M. and Bouck, N.P. (1998) Molecular mediators of bladder cancer. Cancer Res., 58, 1298-1304.
47. Melnyk, O., Zimmerman, M., Kim, K.J. and Shuman, M. (1999) Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model. J. Urol., 161, 960-963.
48. Koza, R.A., Megosh, L.C., Palmieri, M. and O'Brien, T.G. (1991) Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas. Carcinogenesis, 12, 1619-1625.
49. 2 levels in rat colon. Carcinogenesis, 20, 425-430.
50. Szende, B., Juhasz, E., Lapis, K. and Schally, A.V. (1992) Inhibition of two-step urinary bladder carcinogenesis by the somatostatin analogue RC-160. Urol. Res., 20, 383-386.
51. Schulte-Hermann, R., Timmerman-Trosniener, I., Barthel, G. and Bursch, W. (1990) DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res., 50, 5127-5135.
52. Christensen, J.G., Gonzales, A.J., Cattley, R.C. and Goldsworthy, T.L. (1998) Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Differ., 9, 815-825.
53. Pegg, A.E., Secrist, J.A. and Madhubala, R. (1987) Properties of LI210 cells resistant to α-difluoromethylornithine. Cancer Res., 48, 2678-2682.
54. Leinonen, P., Alhonen-Hongist, L., Laine, R., Janne, O.A. and Janne, J. (1987) Human myeloma cells acquire resistance to difluoromethylornithine by amplification of ornithine decarboxylase gene. Biochem. J., 242, 199-203.
55. Chang, B.K., Libby, P.R., Bergeron, R.J. and Porter, C.W. (1988) Modulation of polyamine biosynthesis and transport by oncogene transfection. Biochem. Biophys. Res. Commun., 157, 264-270.
56. Soler, A.P, Gilliard, G., Megosh, L., George, K. and O'Brien, T.G. (1998) Polyamines regulate expression of the neoplastic phenotype in mouse skin. Cancer Res., 58, 1654-1659.
57. Hessels, J., Kingma, A.W., Ferwerda, H., Keiji, J., van den Berg, G.A. and Muskiet, F.A. (1989) Microbial flora in the gastrointestinal tract abolishes cystostatic effects of α-difluoromethylornithine in vivo. Int. J. Cancer, 43, 1155-1164.
58. Seiler, N., Sarhan, S., Grauffel, C., Jones, R., Knodgen, B. and Moulinoux, J.P. (1990) Endogenous and exogenous polyamines in support of tumor growth. Cancer Res., 50, 5077-5083.
59. Bardocz, S., Duguid, T.J., Brown, D.S., Grant, G., Pusztai, A., White, A. and Ralph, A. (1995) The importance of dietary polyamines in cell regeneration and growth. Br. J. Nutr., 73, 819-828.
60. Sarhan, S., Knodgen, B. and Seiler, N. (1992) Polyamine deprivation, malnutrition and tumor growth. Anticancer Res., 12, 457-466.
61. 1-acetyltransferase: the turning point in polyamine metabolism. FASEB J., 7, 653-661.
62. Aboul-Enein, H.Y. and AL-Duraibi, I.A. (1998) Separation of several free polyamines and their acetylated derivatives by ion-pair reversed-phase high performance liquid chromatography. Biomed. Chromatogr., 12, 291-293.
63. Kurihara, H., Matsuzaki, S., Yamazaki, H., Tsukahara, T. and Tamura, M. (1993) Relationship between tissue polyamine levels and malignancy in primary brain tumors. Neurosurgery, 32, 372-375.
64. Taplaz, M., Plager, C., Quesada, J., Benjamin, R., Kantarjian, H. and Gutterman, J. (1986) Difluoromethylornithine and leukocyte interferon: a phase I clinical study in cancer patients. Eur. J. Cancer Clin. Oncol., 22, 685-689.
65. Levin, V.A., Chamberlain, M.C., Prados, M.D., Choucair, A.K., Berger, M.S., Silver, P., Seager, M., Gutin, P.H., Davis, R.L. and Wilson, C.B. (1987) Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent brain tumors. Cancer Treat. Rep., 71, 459-464.